 Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR Q2 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Vince Anzalone - VP, IR Christopher Anzalone - President and CEO Javier San Martin - Chief Medical Officer Ken Myszkowski - CFO James Hamilton - SVP, Discovery and Translational Medicine James Hassard - Chief Commercial Officer Conference Call Participants Maury Raycroft - Jeffries Luca Issi - RBC Capital Ellie Merle - UBS Joel Beatty - Baird Patrick Trucchio - HC Wainwright Mayank Mamtani - B. Riley Securities Keay Nakae - Chardan Mani Foroohar - SVB Securities Operator Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. 